Cargando…
NF-κB/RelA controlled A20 limits TRAIL-induced apoptosis in pancreatic cancer
The emergence of resistance to systemic therapies in pancreatic ductal adenocarcinoma (PDAC) is still a major obstacle in clinical practice. Both, constitutive and inducible NF-κB activity are known as key players in this context. To identify differentially expressed and TRAIL resistance mediating N...
Autores principales: | Geismann, Claudia, Hauser, Charlotte, Grohmann, Frauke, Schneeweis, Christian, Bölter, Nico, Gundlach, Jan-Paul, Schneider, Günter, Röcken, Christoph, Meinhardt, Christian, Schäfer, Heiner, Schreiber, Stefan, Arlt, Alexander |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9810737/ https://www.ncbi.nlm.nih.gov/pubmed/36596765 http://dx.doi.org/10.1038/s41419-022-05535-9 |
Ejemplares similares
-
TRAIL/NF-κB/CX3CL1 Mediated Onco-Immuno Crosstalk Leading to TRAIL Resistance of Pancreatic Cancer Cell Lines
por: Geismann, Claudia, et al.
Publicado: (2018) -
c-Rel is a critical mediator of NF-κB-dependent TRAIL resistance of pancreatic cancer cells
por: Geismann, C, et al.
Publicado: (2014) -
NF-κB Dependent Chemokine Signaling in Pancreatic Cancer
por: Geismann, Claudia, et al.
Publicado: (2019) -
NF-κB/Rel Transcription Factors in Pancreatic Cancer: Focusing on RelA, c-Rel, and RelB
por: Kabacaoglu, Derya, et al.
Publicado: (2019) -
Subinhibitory Concentrations of Bacteriostatic Antibiotics Induce relA-Dependent and relA-Independent Tolerance to β-Lactams
por: Kudrin, Pavel, et al.
Publicado: (2017)